Different Functional and Structural Characteristics between ApoA-I and ApoA-4 in Lipid-Free and Reconstituted HDL State: ApoA-4 Showed Less Anti-Atherogenic Activity

다국어 초록 (Multilingual Abstract)

Apolipoprotein A-I and A-IV are protein constituents of high-density lipoproteins although their functional difference in lipoprotein metabolism is still unclear. To compare anti-atherogenic properties between apoA-I and apoA-4, we characterized both proteins in lipid-free and lipidbound state. In lipid-free state, apoA4 showed two distinct bands, around 78 and 67 Å on native gel electrophoresis, while apoA-I showed scattered band pattern less than 71 Å.
In reconstituted HDL (rHDL) state, apoA-4 showed three major bands around 101 Å and 113 Å, while apoA-I-rHDL showed almost single band around 98 Å size. Lipid-free apoA-I showed 2.9-fold higher phospholipid binding ability than apoA-4. In lipid-free state, BS3-crosslinking revealed that apoA-4 showed less multimerization tendency upto dimer, while apoA-I showed pentamerization. In rHDL state (95:1), apoA-4 was existed as dimer as like as apoA-I. With higher phospholipid content (255:1), five apoA-I and three apoA-4 were required to the bigger rHDL formation. Regardless of particle size, apoA-I-rHDL showed superior LCAT activation ability than apoA-4-rHDL. Uptake of acetylated LDL was inhibited by apoA-I in both lipid-free and lipidbound state, while apoA-4 inhibited it only lipid-free state.
ApoA-4 showed less anti-atherogenic activity with more sensitivity to glycation. In conclusion, apoA-4 showed inferior physiological functions in lipid-bound state, compared with those of apoA-I, to induce more pro-atherosclerotic properties.

참고문헌 (Reference)

1 Davidson, W. S., "The role of apolipoprotein A-I domains in lipid binding" 93 : 13605-13610, 1996

2 Heider, J. G., "The picomole determination of free and total cholesterol in cells in culture" 19 : 514-518, 1978

3 Havel, R. J., "The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum" 34 : 1345-1353, 1955

4 Pearson, K., "Structure of human apolipoprotein A-IV : a distinct domain architecture among exchangeable apolipoproteins with potential functional implications" 43 : 10719-10729, 2004

5 Gomaraschi, M., "Structure and function of the apoA-IV T347S and Q360H common variants" 393 : 126-130, 2010

6 Brouillette, C. G., "Structural models of human apolipoprotein A-I : a critical analysis and review" 1531 : 40-46, 2001

7 Han, J. M., "Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states" 46 : 589-596, 2005

8 McPherson, J. D., "Role of fructose in glycation and cross-linking of proteins" 27 : 1901-1907, 1988

9 Jonas, A., "Regulation of lecithin cholesterol acyltransferase activity" 37 : 209-234, 1998

10 Boguski, M. S., "Rat apolipoprotein A-IV contains 13 tandem repetitions of a 22-amino acid segment with amphipathic helical potential" 81 : 5021-5025, 1984

11 Tubb, M. R., "Purification of recombinant apolipoproteins A-I and A-IV and efficient affinity tag cleavage by tobacco etch virus protease" 50 : 1497-1504, 2009

12 Mahley, R. W., "Plasma lipoproteins : apolipoprotein structure and function" 25 : 1277-1294, 1984

13 Ezeh, B., "Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls" 44 : 1523-1529, 2003

14 Staros, J. V., "N-hydroxysulfosuccinimide active esters : bis(Nhydroxysulfosuccinimide)esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers" 21 : 3950-3955, 1982

15 Chen, P. S., "Microdetermination of phosphorus" 28 : 1756-1758, 1956

16 Matz, C. E., "Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions" 257 : 4535-4540, 1982

17 Fraenkal-Conrat, H., "Methods for investigating essential groups for enzyme activity, Meth" 4 : 247-269, 1957

18 김주윤, "Lipoteichoic Acid Isolated from Lactobacillus plantarum Suppresses LPS-Mediated Atherosclerotic Plaque Inflammation" 한국분자세포생물학회 35 (35): 115-124, 2013

19 Goldberg, I. J., "Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV" 265 : 4266-4272, 1990

20 Pownall, H. J., "Kinetics of lipid-protein interactions : interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines" 17 : 1183-1188, 1978

21 Park, K. H., "Fructated apolipoprotein A-I showed severe structural modifycation and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence" 392 : 295-300, 2010

22 Cho, K. H., "Enhanced delivery of rapamycin by V156K-apoAI high-density lipoprotein inhibits cellular proatherogenic effects and senescence and promotes tissue regeneration" 66 : 1274-1285, 2011

23 Park, K. H., "Elaidic acid(EA)generates dysfunctional high-density lipoproteins and consumption of EA exacerbates hyperlipidemia and fatty liver change in zebrafish" 58 : 1537-1545, 2014

24 Ferretti, G., "Effect of human Apo AIV against lipid peroxidation of very low density lipoproteins" 114 : 45-54, 2002

25 Chen, Y. H., "Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion" 11 : 4120-4131, 1972

26 조경현, "Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications" 한국생화학분자생물학회 42 (42): 393-400, 2009

27 Li, X., "Apolipoprotein AIV Reduces Hepatic Gluconeogenesis through the Nuclear Receptor NR1D1" 289 : 2396-2404, 2014

28 Qin, X., "Apolipoprotein AIV : a potent endogenous inhibitor of lipid oxidation" 274 : 1836-1840, 1998

29 Weinberg, R. B., "Apolipoprotein A-IV polymorphisms and diet-gene interactions" 13 : 125-134, 2002

30 Park, J. Y., "Apolipoprotein A-IV is a novel substrate for matrix metalloproteinases" 151 : 291-298, 2012

31 VerHague, M. A., "Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion" 33 : 2501-2508, 2013

32 Frank, P. G., "Apolipoprotein A-I : structurefunction relationships" 41 : 853-872, 2000

33 Cho, K. H., "ApoA-I mutants V156K and R173C promote antiinflammatory function and antioxidant activities" 36 : 875-882, 2006

34 Beisiegel, U., "An apolipoprotein homolog of rat apolipoprotein A-IV in human plasma. Isolation and partial characterization" 93 : 601-608, 1979

35 Steinmetz, A., "Activation of lecithin : cholesterol acyltransferase by human apolipoprotein A-I" 260 : 2258-2264, 1985

36 Main, L. A., "Activation of human plasma cholesteryl ester transfer protein by human apolipoprotein A-IV" 1300 : 17-24, 1996

37 Tubb, M. R., "A three-dimensional homology model of lipid-free apolipoprotein A-IV using cross-linking and mass spectrometry" 283 : 17314-17323, 2008

38 Markwell, M. A., "A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples" 87 : 206-210, 1978